safety of glp 1 receptor agonists Frontiers Glucagon-Like Peptide-1 Agonist Use in
Description
Global Burden of Cardiovascular Diseases and Risk Factors, 19902019: Update From the GBD 2019 Study
doi: 10.1007/s11695-014-1560-z 11 TsesmeliNCoumarosD
Liraglutide and exenatide have been associated with the development of thyroid C-cell tumors in rodents after lifetime exposure at supratherapeutic doses [169]
Serise aktrer har egne sider med rd, tester for selvvurdering, og kontaktinformasjon til hjelpetjenester
Xu Y, et al
Plum A, Jensen LB, Kristensen JB
